Proposed is a K24 Mid-Career Investigator Award for Dr. Gregory Kirk, Associate Professor at Johns Hopkins University entitled Patient-Oriented Research and Mentorship in HIV and Non-Communicable Diseases (NCDs). To address the dual epidemics of HIV and NCDs, this proposal aims to enhance both investigator and research capacity in the US and in sub-Saharan Africa. Dr. Kirk is an infectious disease specialist with an MPH and PHD in epidemiology jointly appointed in the Department of Epidemiology and the Division of Infectious Diseases in the Schools of Public Health and Medicine, respectively. He has been actively engaged in research, clinical, mentoring and teaching activities at Hopkins for more than a decade with an established track record of research productivity, sustained NIH funding, and effective mentorship leading to mentees' successful transition to academic faculty positions. Dr. Kirk's current research program is directed toward two compelling and complementary primary research objectives: First, to characterize the epidemiology, mechanisms and consequences of non-AIDS outcomes among aging HIV-infected persons, and Second, to improve treatment outcomes among marginalized HIV-infected populations. These research activities are centered in three well-developed and highly-characterized study populations, including the AIDS Linked to the IntraVenous Experience (ALIVE) cohort, the Study of HIV Infection in the Etiology of Lung Disease (SHIELD) cohort, and in studies supported by the newly-initiated HIV and Hepatocellular Carcinoma in Uganda (H2U) Consortium. For each cohort, Dr. Kirk serves as the principal investigator with separate NIH grant support in collaboration with a multidisciplinary team of expert investigators. Each of these study populations support focused, hypothesis-driven investigation of NCDs in the setting of HIV while also providing excellent opportunities for mentees in patient-oriented research. With K24 support, Dr. Kirk proposes expanding his HIV and aging research from a US focus to address the double burden of HIV and NCDs in sub-Saharan Africa. Nested within the substantive clinical research infrastructure of the Infectious Disease Institute (IDI) and Makerere University in Kampala, Uganda, Dr. Kirk and colleagues will characterize the prevalence of seven NCDs among 1000 older HIV-infected Ugandans recruited into the H2U cohort to determine the prevalence and correlates of age-related phenotypes including multimorbidity, frailty, and reduced physical performance. During 2-year follow-up, consequences of these phenotypes will be assessed including HIV care outcomes, disability and mortality. In parallel, Dr. Kirk's successful mentoring approaches employed at Hopkins will be expanded globally to provide intensive mentoring and training in essential academic skills (e.g., grant and scientific writing, study design, presentation skills) to advance the careers of early-stage African investigators.

Public Health Relevance

Proposed is a Mid-Career Investigator Award for Dr. Gregory Kirk, Associate Professor at Johns Hopkins University to augment his patient-oriented research and mentorship in HIV and non-communicable diseases (NCDs). The objective is to enhance his on-going program of HIV and NCD research and mentorship in Baltimore while expanding these activities within his existing research collaborations in Uganda. The key impact from this work will be to enhance both investigator and research capacity in the US and in sub-Saharan Africa for addressing HIV and NCDs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
5K24AI118591-05
Application #
9636432
Study Section
Acquired Immunodeficiency Syndrome Research Review Committee (AIDS)
Program Officer
Bacon, Melanie C
Project Start
2015-02-01
Project End
2021-01-31
Budget Start
2019-02-01
Budget End
2021-01-31
Support Year
5
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429
Yanik, Elizabeth L; Hernández-Ramírez, Raúl U; Qin, Li et al. (2018) Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. J Acquir Immune Defic Syndr 78:499-504
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Boelen, Lies; Debebe, Bisrat; Silveira, Marcos et al. (2018) Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell-mediated control of HIV-1, HCV, and HTLV-1. Sci Immunol 3:
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786
Elion, Richard A; Althoff, Keri N; Zhang, Jinbing et al. (2018) Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr 78:62-72
Drummond, M Bradley; Lambert, Allison A; Hussien, Amira F et al. (2017) HIV Infection Is Independently Associated with Increased CT Scan Lung Density. Acad Radiol 24:137-145
Vergara, C; Thio, C; Latanich, R et al. (2017) Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections. Genes Immun 18:82-87
Dubrow, Robert; Qin, Li; Lin, Haiqun et al. (2017) Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada. J Acquir Immune Defic Syndr 75:382-390
Piggott, Damani A; Muzaale, Abimereki D; Varadhan, Ravi et al. (2017) Frailty and Cause-Specific Hospitalization Among Persons Aging With HIV Infection and Injection Drug Use. J Gerontol A Biol Sci Med Sci 72:389-394

Showing the most recent 10 out of 44 publications